In hepatocellular carcinoma cells, VEGF-induced vasculogenic mimicry is also reported to involve Myocyte Enhancer Factor 2C (MEF2C) together with β-catenin via the p38 MAPK and PKC signaling pathways [165]. Here, MEF2C is linked to hepatocellular carcinoma.